IE
BHVN icon

Israel Englander’s Biohaven BHVN Stock Holding History

Israel Englander’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-42,500
Closed -$480K – 5727
2025
Q4 		$480K Buy
42,500
+17,500
+70% +$217K ﹤0.01% 4968
2025
Q3 		$375K Buy
+25,000
New +$364K ﹤0.01% 5235
2023
Q3 		– Sell
-30,000
Closed -$718K – 6129
2023
Q2 		$718K Buy
+30,000
New +$516K ﹤0.01% 4294
2022
Q4 		– Sell
-454,928
Closed -$67.2M – 6576
2022
Q3 		$67.2M Buy
+454,928
New +$3.3M 0.04% 521

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's BHVN Position: Q2 2026 in Review

Israel Englander reduced its Biohaven (BHVN) stake by 71% in Q2 2026, selling an estimated $11.1M and leaving 417,534 shares worth $6.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2786.

Israel Englander first reported a position in BHVN in Q3 2022 and has held it in 12 quarters since. The position peaked at $153M in Q3 2022. 291 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Israel Englander held 417,534 shares of Biohaven worth $6.21M as of Q2 2026.
  • Israel Englander sold 1,030,352 Biohaven shares in Q2 2026, an estimated $11.1M.
  • Biohaven made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2786 holding.
  • Israel Englander first reported a position in Biohaven in Q3 2022 and has held it in 12 quarters since.
  • Israel Englander's Biohaven position peaked at $153M in Q3 2022.
  • 291 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.